Rhenman & Partners Asset Management AB Diversified Active

CIK: 0001599882 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Jan 19, 2016

Total Value ($000): $661,398 (100.0% shares, 0.0% debt)

Holdings (96)

PRGO Perrigo Co Plc 3.2%
Value ($000) $20,982 Shares 145,000 Est. Cost $165.12 Unrealized -6.9%
Abiomed Inc 3.0%
Value ($000) $19,862 Shares 220,000 Est. Cost $74.57 Unrealized
MDT Medtronic Plc 2.9%
Value ($000) $19,153 Shares 249,000 Est. Cost $58.05 Unrealized +0.9%
Alexion Pharmaceuticals Inc 2.9%
Value ($000) $19,075 Shares 100,000 Est. Cost $164.46 Unrealized
CVS CVS Health Corp 2.7%
Value ($000) $17,599 Shares 180,000 Est. Cost $67.72 Unrealized +7.2%
Allergan Plc 2.6%
Value ($000) $17,188 Shares 55,000 Est. Cost $302.63 Unrealized
ABBV AbbVie Inc 2.2%
Value ($000) $14,573 Shares 246,000 Est. Cost $37.54 Unrealized +1.1%
UNH United Health Group Inc 2.2%
Value ($000) $14,234 Shares 121,000 Est. Cost $89.16 Unrealized +11.4%
PFE Pfizer Inc 2.1%
Value ($000) $14,139 Shares 438,000 Est. Cost $20.60 Unrealized -1.1%
AMGN Amgen Inc 2.0%
Value ($000) $13,311 Shares 82,000 Est. Cost $112.46 Unrealized +3.6%
Cigna Corp 1.9%
Value ($000) $12,731 Shares 87,000 Est. Cost $135.02 Unrealized
BMY Bristol Myers Squibb Co 1.9%
Value ($000) $12,589 Shares 183,000 Est. Cost $39.46 Unrealized +18.3%
GILD Gilead Sciences Inc 1.9%
Value ($000) $12,548 Shares 124,000 Est. Cost $65.44 Unrealized +11.4%
ALKS Alkermes Plc 1.9%
Value ($000) $12,542 Shares 158,000 Est. Cost $55.56 Unrealized +26.0%
Celgene Corp 1.9%
Value ($000) $12,455 Shares 104,000 Est. Cost $113.27 Unrealized
BMRN BioMarin Pharmaceutical Inc 1.9%
Value ($000) $12,362 Shares 118,000 Est. Cost $90.27 Unrealized +15.6%
LLY Eli Lilly & Co 1.9%
Value ($000) $12,302 Shares 146,000 Est. Cost $56.93 Unrealized +22.4%
ELV Anthem Inc 1.9%
Value ($000) $12,271 Shares 88,000 Est. Cost $134.01 Unrealized -10.8%
INCY Incyte Corp Ltd 1.8%
Value ($000) $11,930 Shares 110,000 Est. Cost $70.56 Unrealized +58.1%
MCK McKesson Corp 1.8%
Value ($000) $11,637 Shares 59,000 Est. Cost $191.15 Unrealized -8.7%
REGN Regeneron Pharmaceuticals Inc 1.7%
Value ($000) $11,400 Shares 21,000 Est. Cost $378.17 Unrealized +42.5%
Aetna Inc 1.7%
Value ($000) $11,244 Shares 104,000 Est. Cost $104.69 Unrealized
Walgreens Boots Alliance Inc 1.7%
Value ($000) $11,240 Shares 132,000 Est. Cost $85.15 Unrealized
ZBH Zimmer Biomet Hgs Inc 1.7%
Value ($000) $10,977 Shares 107,000 Est. Cost $91.33 Unrealized -1.4%
HUM Humana Inc 1.6%
Value ($000) $10,889 Shares 61,000 Est. Cost $170.02 Unrealized -4.9%
St Jude Medical Inc 1.6%
Value ($000) $10,810 Shares 175,000 Est. Cost $64.79 Unrealized
BDX Becton Dickinson & Co 1.6%
Value ($000) $10,632 Shares 69,000 Est. Cost $118.02 Unrealized +4.6%
Laboratory Corp of America Hgs 1.5%
Value ($000) $10,015 Shares 81,000 Est. Cost $121.84 Unrealized
CNC Centene Corp 1.5%
Value ($000) $9,806 Shares 149,000 Est. Cost $30.22 Unrealized -2.0%
Nektar Therapeutics 1.5%
Value ($000) $9,790 Shares 581,000 Est. Cost $11.22 Unrealized
CAH Cardinal Health Inc 1.4%
Value ($000) $9,284 Shares 104,000 Est. Cost $60.16 Unrealized +5.7%
DXCM Dexcom Inc 1.3%
Value ($000) $8,600 Shares 105,000 Est. Cost $12.76 Unrealized +63.0%
Health Net Inc 1.3%
Value ($000) $8,352 Shares 122,000 Est. Cost $60.22 Unrealized
Medivation Inc 1.2%
Value ($000) $7,734 Shares 160,000 Est. Cost $55.15 Unrealized
HALO Halozyme Therapeutics Inc 1.1%
Value ($000) $7,105 Shares 410,000 Est. Cost $16.63 Unrealized -4.1%
Endo International Plc 1.1%
Value ($000) $7,102 Shares 116,000 Est. Cost $73.88 Unrealized
VRTX Vertex Pharmaceuticals Inc 1.1%
Value ($000) $7,046 Shares 56,000 Est. Cost $106.88 Unrealized +12.9%
Cempra Inc 1.1%
Value ($000) $7,035 Shares 226,000 Est. Cost $33.87 Unrealized
Valeant Pharm Intl Inc 1.1%
Value ($000) $7,014 Shares 69,000 Est. Cost $101.65 Unrealized
Intra-Cellular Therapies Inc 1.0%
Value ($000) $6,778 Shares 126,000 Est. Cost $19.23 Unrealized
HCA HCA Holdings Inc 1.0%
Value ($000) $6,492 Shares 96,000 Est. Cost $71.44 Unrealized -9.2%
Express Scripts Hg Co 1.0%
Value ($000) $6,468 Shares 74,000 Est. Cost $87.52 Unrealized
Keryx Biopharmaceuticals Inc 0.9%
Value ($000) $6,227 Shares 1,233,000 Est. Cost $6.26 Unrealized
Revance Therapeutics Inc 0.9%
Value ($000) $5,910 Shares 173,000 Est. Cost $25.76 Unrealized
JAZZ Jazz Pharmaceuticals Plc 0.9%
Value ($000) $5,904 Shares 42,000 Est. Cost $170.18 Unrealized -18.6%
ALNY Alnylam Pharmaceuticals Inc 0.9%
Value ($000) $5,837 Shares 62,000 Est. Cost $97.77 Unrealized -5.2%
Rite Aid Corp 0.8%
Value ($000) $5,316 Shares 678,000 Est. Cost $7.08 Unrealized
UHS Universal Health Services Inc B 0.8%
Value ($000) $5,258 Shares 44,000 Est. Cost $105.74 Unrealized +10.8%
BSX Boston Scientific Corp 0.8%
Value ($000) $5,053 Shares 274,000 Est. Cost $17.92 Unrealized 0.0%
Celldex Therapeutics Inc 0.8%
Value ($000) $5,018 Shares 320,000 Est. Cost $17.68 Unrealized
Cooper Companies Inc (The) 0.8%
Value ($000) $4,965 Shares 37,000 Est. Cost $173.24 Unrealized
Cerner Corp 0.7%
Value ($000) $4,934 Shares 82,000 Est. Cost $62.08 Unrealized
COR AmerisourceBergen Corp 0.7%
Value ($000) $4,771 Shares 46,000 Est. Cost $62.18 Unrealized +17.0%
Lion Biotechnologies Inc 0.7%
Value ($000) $4,439 Shares 575,000 Est. Cost $8.54 Unrealized
ACAD Acadia Pharmaceuticals Inc 0.6%
Value ($000) $4,278 Shares 120,000 Est. Cost $25.97 Unrealized +35.7%
Endologix Inc 0.6%
Value ($000) $4,158 Shares 420,000 Est. Cost $12.23 Unrealized
IONS Ionis Pharmaceuticals Inc 0.6%
Value ($000) $4,149 Shares 67,000 Est. Cost $53.96 Unrealized 0.0%
LIVN Livanova Plc 0.6%
Value ($000) $3,918 Shares 66,000 Est. Cost $60.69 Unrealized 0.0%
Intercept Pharmaceuticals Inc 0.6%
Value ($000) $3,883 Shares 26,000 Est. Cost $211.96 Unrealized
SUPN Supernus Pharmaceuticals Inc 0.6%
Value ($000) $3,871 Shares 288,000 Est. Cost $8.32 Unrealized +85.8%
EW Edwards Lifesciences Corp 0.6%
Value ($000) $3,870 Shares 49,000 Est. Cost $20.05 Unrealized +29.5%
ZELTIQ Aesthetics Inc 0.6%
Value ($000) $3,652 Shares 128,000 Est. Cost $29.93 Unrealized
PODD Insulet Corp 0.5%
Value ($000) $3,630 Shares 96,000 Est. Cost $34.93 Unrealized -3.6%
Baxalta Inc 0.5%
Value ($000) $3,435 Shares 88,000 Est. Cost $39.03 Unrealized
Heartware Intl Inc 0.5%
Value ($000) $3,377 Shares 67,000 Est. Cost $55.99 Unrealized
Portola Pharmaceuticals Inc 0.5%
Value ($000) $3,190 Shares 62,000 Est. Cost $45.55 Unrealized
Horizon Pharma Plc 0.5%
Value ($000) $3,164 Shares 146,000 Est. Cost $21.67 Unrealized
MGNX Macrogenics Inc 0.4%
Value ($000) $2,911 Shares 94,000 Est. Cost $27.20 Unrealized +11.7%
Achillion Pharmaceuticals Inc 0.4%
Value ($000) $2,870 Shares 266,000 Est. Cost $9.71 Unrealized
Cepheid Inc 0.4%
Value ($000) $2,740 Shares 75,000 Est. Cost $44.32 Unrealized
Ariad Pharmaceuticals Inc 0.4%
Value ($000) $2,688 Shares 430,000 Est. Cost $6.79 Unrealized
PCRX Pacira Pharmaceuticals Inc 0.4%
Value ($000) $2,688 Shares 35,000 Est. Cost $56.62 Unrealized 0.0%
Tesaro Inc 0.4%
Value ($000) $2,663 Shares 50,899 Est. Cost $31.85 Unrealized
XNCR Xencor Inc 0.4%
Value ($000) $2,651 Shares 181,303 Est. Cost $14.68 Unrealized -8.4%
EXEL Exelixis Inc 0.4%
Value ($000) $2,594 Shares 460,000 Est. Cost $5.60 Unrealized 0.0%
Rigel Pharmaceuticals Inc 0.4%
Value ($000) $2,558 Shares 844,313 Est. Cost $3.57 Unrealized
Clovis Oncology Inc 0.4%
Value ($000) $2,555 Shares 73,000 Est. Cost $44.36 Unrealized
CYH Community Health Syst Inc 0.4%
Value ($000) $2,520 Shares 95,000 Est. Cost $41.54 Unrealized -37.8%
Tandem Diabetes Care Inc 0.4%
Value ($000) $2,468 Shares 209,000 Est. Cost $12.69 Unrealized
Catabasis Pharmaceuticals Inc 0.4%
Value ($000) $2,428 Shares 306,227 Est. Cost $11.66 Unrealized
Sagent Pharmaceuticals Inc 0.4%
Value ($000) $2,387 Shares 150,000 Est. Cost $15.91 Unrealized
OMCL Omnicell Inc 0.3%
Value ($000) $2,300 Shares 74,000 Est. Cost $32.97 Unrealized -10.5%
Chimerix Inc 0.3%
Value ($000) $2,291 Shares 256,000 Est. Cost $16.70 Unrealized
Tetraphase Pharmaceuticals Inc 0.3%
Value ($000) $2,257 Shares 225,000 Est. Cost $21.39 Unrealized
ESPR Esperion Therapeutics Inc 0.3%
Value ($000) $2,226 Shares 100,000 Est. Cost $22.47 Unrealized +12.3%
Orexigen Therapeutics Inc 0.3%
Value ($000) $2,045 Shares 1,189,000 Est. Cost $5.13 Unrealized
Regulus Therapeutic Inc 0.3%
Value ($000) $1,744 Shares 200,000 Est. Cost $6.54 Unrealized
Mirati Therapeutics Inc 0.2%
Value ($000) $1,580 Shares 50,000 Est. Cost $31.48 Unrealized
Array BioPharma Inc 0.2%
Value ($000) $1,561 Shares 370,000 Est. Cost $4.79 Unrealized
FibroGen Inc 0.2%
Value ($000) $1,524 Shares 50,000 Est. Cost $30.48 Unrealized
Avalanche Biotechnologies Inc 0.2%
Value ($000) $1,466 Shares 154,006 Est. Cost $23.02 Unrealized
Dynavax Technologies Corp 0.2%
Value ($000) $1,329 Shares 55,000 Est. Cost $23.42 Unrealized
HOLX Hologic Inc 0.2%
Value ($000) $1,288 Shares 33,301 Est. Cost $24.29 Unrealized +60.2%
Anthera Pharmaceuticals Inc 0.2%
Value ($000) $1,160 Shares 250,000 Est. Cost $3.59 Unrealized
BIND Therapeutics Inc 0.0%
Value ($000) $306 Shares 133,535 Est. Cost $11.18 Unrealized
Threshold Pharmaceuticals 0.0%
Value ($000) $97 Shares 201,537 Est. Cost $4.08 Unrealized